🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Midday movers: Nvidia, Eli Lilly rise; BP, Novo Nordisk fall

Published 07/09/2024, 07:44 AM
Updated 07/09/2024, 11:34 AM
© Reuters
INTC
-
LLY
-
NVDA
-
PFE
-
BP
-
NVO
-
NOW
-
LCID
-
PATH
-

(Updated - July 9, 2024 11:31 AM EDT)

Investing.com -- U.S. stock futures edged higher Tuesday following the start of two-day testimony from Fed chief Jerome Powell to Congress. Powell said the economy has made considerable progress toward the Federal Reserve's 2 percent inflation goal, and labor market conditions have cooled while remaining strong.

Here are some of the biggest U.S. stock movers today:

  • Intel (NASDAQ:INTC) stock fell 0.1% after gaining over 6% in the previous session, while Nvidia (NASDAQ:NVDA) rose 3% and Marvell (NASDAQ:MRVL) was down 1.2%, as stocks linked with AI were mixed.

  • Pfizer (NYSE:PFE) (PFE) stock fell 2% after it announced its chief scientific officer Mikael Dolsten would step down after a more than 15-year career at the drugmaker.

  • Eli Lilly (NYSE:LLY) stock rose 0.8% and Novo Nordisk (NYSE:NVO) stock fell 1.8% after the publication of a data analysis showing Eli Lilly's treatment Mounjaro leads to faster and greater weight loss than Novo’s popular obesity drug Wegovy.

  • Lucid Group (NASDAQ:LCID) stock fell 3% after the EV manufacturer will have to recall over 5,000 of its 2022-2023 Air luxury sedans due to a software error that could cause a loss of power.

  • BP (NYSE:BP) ADRs fell 4.1% after the energy giant warned that its second-quarter results will be hit by lower refining margins and it also expects to post an impairment of up to $2 billion.

  • Helen of Troy (HELE) stock slumped 30% after the consumer products company reported disappointing first-quarter results and slashed its full-year outlook, amid particular weakness in its beauty and wellness business.

  • UiPath Inc. (NYSE:PATH) fell 7% after it announced plans to cut around 10% of its global workforce.

  • ServiceNow (NYSE:NOW) declined 3.5%, extending yesterday's fall, after analysts downgraded the stock to "sell" due to concerns about risks to its business in the second half of the year.


Additional reporting by Louis Juricic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.